News & Updates

Antipsychotic use lowers work disability risk

12 Dec 2022

Use of antipsychotics, particularly long-acting injectables, results in nearly 30‒50-percent reduced risk of work disability among individuals with first-episode nonaffective psychosis compared with nonuse, a study has shown. This benefit persists beyond 5 years after first diagnosis.

Antipsychotic use lowers work disability risk

12 Dec 2022

Depressive symptoms worsen cognition, gait, comorbidities in older adults

10 Dec 2022

Among older adults, depressive symptoms aggravate the worsening of cognition, gait speed, and other comorbidities on disability, a recent study has found.

Depressive symptoms worsen cognition, gait, comorbidities in older adults

10 Dec 2022

Mindfulness-based classes help fight depression during pregnancy, postpartum period

07 Dec 2022 by

A group-based mindfulness intervention during pregnancy appears to favourably affect the well-being of women, with the benefit persisting through the postpartum period, as shown in a recent study.

Mindfulness-based classes help fight depression during pregnancy, postpartum period

07 Dec 2022

Singapore’s youth endure high rates of bullying

07 Dec 2022 by

Peer victimization, or bullying, appears to be highly prevalent among youth, according to a recent Singapore study. In turn, bullying aggravates depressive symptoms and worsens quality of life.

Singapore’s youth endure high rates of bullying

07 Dec 2022

Hair zinc levels a potential biomarker for assessing psychosis risk in teens

06 Dec 2022

Lower levels of zinc in hair may be a warning signal for psychosis among treatment-naïve adolescents, a study has found.

Hair zinc levels a potential biomarker for assessing psychosis risk in teens

06 Dec 2022

Group CBT may help improve emotion regulation in adults with autism

04 Dec 2022

Among adults with autism spectrum disorder (ASD), group-based cognitive behavioural therapy (CBT) appears to yield modest improvements in emotion regulation, a recent study has found.

Group CBT may help improve emotion regulation in adults with autism

04 Dec 2022

Mindfulness programme as effective as escitalopram in treating anxiety

04 Dec 2022 by

Mindfulness-based stress reduction (MBSR) course is safe and as effective as first-line escitalopram for treatment of anxiety disorders, a randomized control trial has shown.

Mindfulness programme as effective as escitalopram in treating anxiety

04 Dec 2022

ADHD medication use carries no excess risk of cardiovascular diseases

02 Dec 2022

Users of attention-deficit/hyperactivity disorder (ADHD) medications across age groups do not appear to be at increased risk of cardiovascular diseases (CVDs), although a modest risk increase of cardiac arrest or tachyarrhythmias could not be ruled out, according to the results of a meta-analysis.